🇮🇳 QSC Peptides India  ·  Order from QSC →

Buy Tirzepatide in India

International Shipping CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly, the first of its class to exceed 20% in Phase 3. QSC international shipping to India.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Shipped to India

From USD 62 · International shipping 10-15 business days. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.

Buy Tirzepatide at QSC →

Shipping Details for India

RegionDelivery Time
Mumbai, Delhi, Bangalore, Chennai10-14 business days
Hyderabad, Pune, Kolkata, Ahmedabad10-15 business days
Tier 2 cities (Jaipur, Lucknow, etc.)12-18 business days
Tier 3 and rural India15-20 business days
Tracking numberIncluded with all orders
Shipping originInternational (US/Asia/EU)
Shipping costFree
Purity>=99% HPLC
Certificate of AnalysisJanoshik (independent lab)
PaymentBitcoin / USDT

Tirzepatide — Variants and USD Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
USD 62
Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
USD 100
Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
USD 138
Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue and reduces hepatic gluconeogenesis — of particular relevance given India's high rates of insulin resistance and T2DM.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4% at 72 weeks. First GLP-1 compound to exceed 20% in a published Phase 3 trial.

Available Across India

QSC ships Tirzepatide internationally to all Indian states and union territories: Maharashtra (Mumbai, Pune), Delhi NCR, Karnataka (Bangalore), Tamil Nadu (Chennai), Telangana (Hyderabad), West Bengal (Kolkata), Gujarat (Ahmedabad, Surat), Rajasthan (Jaipur), Uttar Pradesh (Lucknow, Kanpur, Noida), and all other states. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016, not a reseller. Purity >=99% HPLC with verifiable Janoshik COA at janoshik.com. Payment: Bitcoin (BTC) and USDT/USDC only. Prices in USD.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped internationally by QSC.